Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1034-2015Class II

Animas Vibe Insulin Infusion Pump. This product is indicated for continuous subcutaneous infusion of insulin...

Animas Corp. / initiated 2011-09-06 / Terminated / root cause: software

Animas Corporation began a recall of Animas Vibe Insulin Infusion Pump. This product is indicated for continuous subcutaneous infusion of insulin for the treatment of diabetes and has a continuous... on . FDA classified it as Class II and gives the reason as "Calibration factors in the pump overwritten during a programming step. The force sensor could send a lower signal value to the pump processor, with loss of prime warnings, occlusion alarms and the pump unable to detect...". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1034-2015
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Animas Corp.
Product
Animas Vibe Insulin Infusion Pump. This product is indicated for continuous subcutaneous infusion of insulin for the treatment of diabetes and has a continuous glucose monitoring feature.
Product code
OYC Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor
Reason for recall
Calibration factors in the pump overwritten during a programming step. The force sensor could send a lower signal value to the pump processor, with loss of prime warnings, occlusion alarms and the pump unable to detect a cartridge during the prime sequence. Field action initiated 8/29/2011.
Root cause tag
software
FDA root cause
Software design (manufacturing process)
Action
The field action was initiated on 8/29/2011 and comprised communication to patients and distributors using email, letters and verbal communication. In addition, notifications were sent to those Health Care Professionals who had patients that were affected by this field action. Health Authorities were notified in those countries where the pump had been distributed (France, Germany, Sweden and United Kingdom) or was in the hands of patients. Replacement product was provided to distributors and end users who were identified as having affected product.
Quantity in commerce
1235
Distribution
No US distribution, Distributors are located in France, Germany, Sweden and United Kingdom.
Product codes and lots
Model Number(s):   100515-63 100510-63 100514-63 100512-63 100511-63 101200-03 100201-03 101202-03 101204-03 101205-03 101200-53 101202-53 101205-53 101200-02 101200-57 101201-57 101202-57 101204-57 101205-57 101200-63 101201-63 101202-63 101204-63 101205-63 101206-63

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1034-2015
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1034-2015Class IITerminatedVoluntary: Firm initiated